X-linked Hypophosphatemia (XLH) research hub

Effective Dosing of Burosumab in XLH

This study looks at how different doses of a medicine called Burosumab (Crysvita) work for children with a rare bone condition called X-linked Hypophosphataemia (XLH). Researchers are reviewing existing patient records from different hospitals to see which doses are most effective.